Skip to main content
SpringerLink
Log in

Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells

  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Surgical resection of gastric cancer has made significant progress, but majority of patients with advanced gastric cancer face relapse and die within five years. In this study, the antitumor activity of ex vivo expanded T cells against the human gastric cancer was evaluated in vitro and in vivo. Human peripheral blood mononuclear cells were cultured with IL-2-containing medium in anti-CD3 antibody-coated flasks for 5 days, followed by incubation in IL-2-containing medium for 9 days. The resulting populations were mostly CD3+ T cells (97%) and comprised 1% CD3−CD56+, 36% CD3+CD56+, 11% CD4+, and 80% CD8+. This heterogeneous cell population was also called cytokine-induced killer (CIK) cells. CIK cells strongly produced IFN-γ, moderately TNF-α, but not IL-2 and IL-4. At an effector-target cell ratio of 30:1, CIK cells destroyed 58% of MKN74 human gastric cancer cells, as measured by the 51Cr-release assay. In addition, CIK cells at doses of 3 and 10 million cells per mouse inhibited 58% and 78% of MKN74 tumor growth in nude mouse xenograft assays, respectively. This study suggests that CIK cells may be used as an adoptive immunotherapy for gastric cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Baker, J., Verneris, M. R., Ito, M., Shizuru, J. A., and Negrin, R. S., Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood, 97, 2923–2931 (2001).

    Article  CAS  PubMed  Google Scholar 

  • Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., and Brugger, W., Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood, 96, 3102–3108 (2000).

    CAS  PubMed  Google Scholar 

  • De Vita, F., Giuliani, F., Orditura, M., Maiello, E., Galizia, G., Di Martino, N., Montemurro, F., Carteni, G., Manzione, L., Romito, S., Gebbia, V., Ciardiello, F., Catalano, G., and Colucci, G., Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Ann. Oncol., 18, 1354–1358 (2007).

    Article  PubMed  Google Scholar 

  • Guo, D. L., Dong, M., Wang, L., Sun, L. P., and Yuan, Y., Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori-associated gastric diseases. World J. Gastroenterol., 8, 1009–1013 (2002).

    CAS  PubMed  Google Scholar 

  • Hallissey, M. T., Dunn, J. A., Ward, L. C., and Allum, W. H., The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet, 343, 1309–1312 (1994).

    Article  CAS  PubMed  Google Scholar 

  • Han, S. B., Park, S. H., Jeon, Y. J., Kim, Y. K., Kim, H. M., and Yang, K. H., Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis. J. Pharmacol. Exp. Ther., 299, 415–425 (2001).

    CAS  PubMed  Google Scholar 

  • Han, S. B., Lee, C. W., Yoon, Y. D., Kang, J. S., Lee, K. H., Yoon, W. K., Kim, Y. K., Lee, K., Park, S. K., and Kim, H. M., Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A. Biochem. Pharmacol., 70, 1518–1526 (2005).

    Article  CAS  PubMed  Google Scholar 

  • Hoshino, T., Seki, N., Kikuchi, M., Kuramoto, T., Iwamoto, O., Kodama, I., Koufuji, K., Takeda, J., and Itoh, K., HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer. Int. J. Cancer, 70, 631–638 (1997).

    Article  CAS  PubMed  Google Scholar 

  • Jiang, J., Xu, N., Wu, C., Deng, H., Lu, M., Li, M., Xu, B., Wu, J., Wang, R., Xu, J., and Nilsson-Ehle, P., Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res., 26, 2237–2242 (2006).

    CAS  PubMed  Google Scholar 

  • Kalergis, A. M. and Ravetch, J. V., Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J. Exp. Med., 195, 1653–1659 (2002).

    Article  CAS  PubMed  Google Scholar 

  • Kim, H. M., Kang, J. S., Lim, J., Park, S. K., Lee, K., Yoon, Y. D., Lee, C. W., Lee, K. H., Han, G., Yang, K. H., Kim, Y. J., Kim, Y., and Han, S. B., Inhibition of human ovarian tumor growth by cytokine-induced killer cells. Arch. Pharm. Res., 30, 1464–1470 (2007a).

    Article  CAS  PubMed  Google Scholar 

  • Kim, H. M., Lim, J., Park, S. K., Kang, J. S., Lee, K., Lee, C. W., Lee, K. H., Yun, M. J., Yang, K. H., Han, G., Kwon, S. W., Kim, Y., and Han, S. B., Antitumor activity of cytokine-induced killer cells against human lung cancer. Int. Immunopharmacol., 7, 1802–1807 (2007b).

    Article  CAS  PubMed  Google Scholar 

  • Kim, H. M., Lim, J., Yoon, Y. D., Ahn, J. M., Kang, J. S., Lee, K., Park, S. K., Jeong, Y. J., Kim, J. M., Han, G., Yang, K. H., Kim, Y. J., Kim, Y., and Han, S. B., Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma. Int. Immunopharmacol., 7, 1793–1801 (2007c).

    Article  CAS  PubMed  Google Scholar 

  • Kondo, K., Kaneko, T., Baba, M., and Konno, H., VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol. Pharm. Bull., 30, 633–637 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Kono, K., Rongcun, Y., Charo, J., Ichihara, F., Celis, E., Sette, A., Appella, E., Sekikawa, T., Matsumoto, Y., and Kiessling, R., Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes. Int. J. Cancer, 78, 202–208 (1998).

    Article  CAS  PubMed  Google Scholar 

  • Kornacker, M., Moldenhauer, G., Herbst, M., Weilguni, E., Tita-Nwa, F., Harter, C., Hensel, M., and Ho, A. D., Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma. Int. J. Cancer, 119, 1377–1382 (2006).

    Article  CAS  PubMed  Google Scholar 

  • Lim, L., Michael, M., Mann, G. B., and Leong, T., Adjuvant therapy in gastric cancer. J. Clin. Oncol., 23, 6220–6232 (2005).

    Article  CAS  PubMed  Google Scholar 

  • Lu, P. H. and Negrin, R. S., A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J. Immunol., 153, 1687–1696 (1994).

    CAS  PubMed  Google Scholar 

  • Moehler, M., Lyros, O., Gockel, I., Galle, P. R., and Lang, H., Multidisciplinary management of gastric and gastroesophageal cancers. World J. Gastroenterol., 14, 3773–3780 (2008).

    Article  PubMed  Google Scholar 

  • Nie, Y., Wu, K., Yang, J., Tian, F., Li, L., Chen, B., and Fan, D., Induction of T lymphocytes specific to human gastric cancer using HLA-A matched allogeneic gastric tumor cells. J. Immunother., 26, 403–411 (2003).

    Article  CAS  PubMed  Google Scholar 

  • Nishimura, R., Baker, J., Beilhack, A., Zeiser, R., Olson, J. A., Sega, E. I., Karimi, M., and Negrin, R. S., In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. Blood, 112, 2563–2574 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Ohshita, A., Yamaguchi, Y., Minami, K., Okita, R., and Toge, T., Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients. Int. J. Oncol., 28, 1163–1171 (2006).

    CAS  PubMed  Google Scholar 

  • Okada, N., Cell delivery system: a novel strategy to improve the efficacy of cancer immunotherapy by manipulation of immune cell trafficking and biodistribution. Biol. Pharm. Bull., 28, 1543–1550 (2005).

    Article  CAS  PubMed  Google Scholar 

  • Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., Higashino, M., Yamamura, Y., Kurita, A., and Arai, K., Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N. Engl. J. Med., 357, 1810–1820 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Sasako, M., Principles of surgical treatment for curable gastric cancer. J. Clin. Oncol., 21, 274s–275s (2003).

    Article  PubMed  Google Scholar 

  • Shida, D., Kitayama, J., Mori, K., Watanabe, T., and Nagawa, H., Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells. Cancer Res., 65, 9159–9163 (2005).

    Article  CAS  PubMed  Google Scholar 

  • Sun, S., Li, X. M., Li, X. D., and Yang, W. S., Studies on inducing apoptosis effects and mechanism of CIK cells for MGC-803 gastric cancer cell lines. Cancer Biother. Radiopharm., 20, 173–180 (2005).

    Article  CAS  PubMed  Google Scholar 

  • Takayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., and Kakizoe, T., Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet, 356, 802–807 (2000).

    Article  CAS  PubMed  Google Scholar 

  • Thorne, S. H., Negrin, R. S., and Contag, C. H., Synergistic antitumor effects of immune cell-viral biotherapy. Science, 311, 1780–1784 (2006).

    Article  CAS  PubMed  Google Scholar 

  • Wang, W., Epler, J., Salazar, L. G., and Riddell, S. R., Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1. Cancer Res., 66, 6826–6833 (2006).

    Article  CAS  PubMed  Google Scholar 

  • Wu, C., Jiang, J., Shi, L., and Xu, N., Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer. Anticancer Res., 28, 3997–4002 (2008).

    CAS  PubMed  Google Scholar 

  • Wu, K., Nie, Y., Guo, C., Chen, Y., Ding, J., and Fan, D., Molecular basis of therapeutic approaches to gastric cancer. J. Gastroenterol. Hepatol., 24, 37–41 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Wu, Y., Wang, L., and Zhang, Y., Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy. Cell. Mol. Immunol., 1, 351–356 (2004).

    PubMed  Google Scholar 

  • Yang, X. J., Huang, J. A., Lei, W., Zhu, Y. B., and Zhang, X. G., Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo. Ai Zheng, 25, 1329–1333 (2006).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and Medical Research Center (CICT), Chungbuk National University, Cheongju, 361-763, Korea

    Yeon Jin Kim, Hong Kyung Lee, Hwa Sun Ryu, Jee Youn Kim, Jin Tae Hong, Youngsoo Kim & Sang-Bae Han

  2. Innocell Ltd., SJ Technoville, Seoul, 153-769, Korea

    Jaeseung Lim

  3. Korea Research Institute of Bioscience and Biotechnology, Ochang, 363-883, Korea

    Jong Soon Kang & Hwan Mook Kim

Authors
  1. Yeon Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaeseung Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jong Soon Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hwan Mook Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hong Kyung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hwa Sun Ryu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jee Youn Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jin Tae Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Youngsoo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sang-Bae Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sang-Bae Han.

Additional information

These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, Y.J., Lim, J., Kang, J.S. et al. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. Arch. Pharm. Res. 33, 1789–1795 (2010). https://doi.org/10.1007/s12272-010-1111-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-010-1111-7

Key words

Search

Navigation